<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00319345</url>
  </required_header>
  <id_info>
    <org_study_id>CHUN-LM-0001</org_study_id>
    <nct_id>NCT00319345</nct_id>
  </id_info>
  <brief_title>Sodium-Lactate and Traumatic Brain Injury</brief_title>
  <official_title>Sodium-Lactate Versus Mannitol in the Treatment of Intracranial Hypertensive Episodes in Severe Traumatic Brain Injured Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut d'Anesthesiologie des Alpes Maritimes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>PT Kalbe Farma TBK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut d'Anesthesiologie des Alpes Maritimes</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effect of bolus of either sodium-lactate or&#xD;
      mannitol on the evolution of intracranial pressure (ICP) during intracranial hypertensive&#xD;
      episodes (IHE)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Osmotherapy with mannitol remains the first treatment currently recommended to treat&#xD;
      intracranial hypertension in severe head injury.However, this treatment in not always&#xD;
      efficient and is associated with side-effects and a transitory action. Hypertonic&#xD;
      sodium-lactate, by its osmotic and energetic properties could be superior to mannitol to&#xD;
      decrease ICP. Study objectives : to compare the effect of mannitol and sodium-lactate on ICP&#xD;
      at the fourth hour after the start of infusion during IHE in severe traumatic brain injury&#xD;
      (TBI) (main endpoint) ; to compare the percentage of successfully treated episodes between&#xD;
      both treatments and to compare the neurological status after one year of evolution (glasgow&#xD;
      outcome score)(secondary endpoints)&#xD;
&#xD;
      Patients inclusion : adult severe TBI (glasgow coma score &lt; 9) &lt; 66 yrs Exclusion criteria :&#xD;
      polytrauma, bilateral fixed dilated pupils, motor score &lt; 4, neurosurgery, prolonged episode&#xD;
      of hypoxia or arterial hypotension, 34 patients included from november 2003 to november 2004&#xD;
      and randomized into two groups : MAN group receiving mannitol 20% 100 ml in 15 min (17&#xD;
      patients, 36 episodes of IHE treated) and LAC group receiving semimolar sodium-lactate 100 ml&#xD;
      in 15 min (17 patients, 37 episodes of IHE treated). For ethical reasons a rescue treatment&#xD;
      in a crossover fashion was performed for each episode of IHE when the randomized treatment&#xD;
      failed.&#xD;
&#xD;
      Follow-up : one year after the TBI. Study end : november 30, 2005&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>November 2003</start_date>
  <completion_date>November 2005</completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficiency to decrease ICP during IHE episodes</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of successful treatment, neurological status (Glasgow outcome score) after one year of evolution</measure>
  </secondary_outcome>
  <enrollment>34</enrollment>
  <condition>Severe Trauma Brain Injury</condition>
  <condition>Intracranial Hypertension</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mannitol, Sodium-Lactate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age between 18 and 65 years&#xD;
&#xD;
          -  severe traumatic brain injury&#xD;
&#xD;
          -  prehospital glasgow coma scale &lt; 9&#xD;
&#xD;
          -  rapid neurological worsening before admission&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  neurosurgical intervention&#xD;
&#xD;
          -  polytrauma&#xD;
&#xD;
          -  bilatéral fixed dilated pupils&#xD;
&#xD;
          -  motorscore &lt; 4&#xD;
&#xD;
          -  prolonged episode of hypoxia or arterial hypotension&#xD;
&#xD;
          -  abundant rinorrhea&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carole R ICHAI, MD-PhD</last_name>
    <role>Study Director</role>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Nice</name>
      <address>
        <city>Nice</city>
        <state>Alpes Maritimes</state>
        <zip>06006</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2006</verification_date>
  <study_first_submitted>April 27, 2006</study_first_submitted>
  <study_first_submitted_qc>April 27, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2006</study_first_posted>
  <last_update_submitted>June 22, 2010</last_update_submitted>
  <last_update_submitted_qc>June 22, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2010</last_update_posted>
  <keyword>Traumatic brain injury</keyword>
  <keyword>Intracranial pressure</keyword>
  <keyword>Osmotherapy</keyword>
  <keyword>Glasgow outcome score</keyword>
  <keyword>Mannitol</keyword>
  <keyword>Sodium-Lactate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Intracranial Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mannitol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

